2011-004091-12: A Clinical Study to Evaluate the Safety and Efficacy of Injections of Cells from another person for the Treatment of Subjects with Intermittent Claudication (IC). |
|
|
| Ongoing | 2 | 150 | Europe | PLX-PAD, adherent stromal cells (ASC), Suspension for injection | Pluristem Ltd., Pluristem Ltd. | Intermittent Claudication (IC); Fontaine class IIb; Rutherford category 2-3, Intermittent Claudication (IC) (Peripheral arterial occlusive disease); Fontaine class IIb; Rutherford category 2-3, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2020-001857-31: A clinical study to test if a drug called PLX-PAD is both safe and can help in the treatment of COVID-19 patients |
|
|
| Not yet recruiting | 2 | 40 | Europe, RoW | PLX-PAD, Dispersion for injection | Pluristem Ltd., Pluristem Ltd. | Pneumonia or Acute Respiratory Distress Syndrome (ARDS) caused by severe COVID-19 disease, COVID-19–related critical illness, Diseases [C] - Virus Diseases [C02] | | | | |